Brief: Vaxcyte Q1 Operating Expenses USD 345.85 Million
06/05/2026 21:05
May 06 (Reuters) - Vaxcyte Q1 net income USD -320.622 million vs. IBES estimate USD -256.4 million.
May 06 (Reuters) - Vaxcyte Q1 net income USD -320.622 million vs. IBES estimate USD -256.4 million.